The Relative Safety of Ephedra Compared with Other Herbal Products

  1. Richard L. Kingston, PharmD; and
  2. Stephen W. Borron, MD, MS
  1. From PROSAR International Poison Center; St. Paul, MN 55108, University of Minnesota, Minneapolis, MN 55455; and International Toxicology Consultants; Washington, DC 20036.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified …

    « Previous | Next Article »Table of Contents